Aquinox Analyst & Investor Day

The W Hotel Lexington, February 9, 2018

Presentations start at 10:00 am EDT (registration/breakfast at 9:30 am EDT)

The W Hotel, 541 Lexington Ave
Great Room 1
New York, NY 10017

Registration required - Please RSVP to Bill Kadel at

General Agenda

  • Overview of IC/BPS Diagnosis & Treatment Landscape followed by Q&A 
    • Philip Hanno, MD, MPH – Stanford University Dept. of Urology
  • IC/BPS Clinical Program Update 
    • Barbara Troupin, MD, MBA – Aquinox CMO, VP Clinical Development & Regulatory Affairs
  • IC/BPS Commercial Landscape & Opportunity followed by Q&A 
    • Abigail Jenkins - Chief Commercial Officer & US Business Head
  • Open Lunch
RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

Aquinox Pharmaceuticals, Inc. [AQXP] US$63 MM MCap
Dis­cov­er­ing and de­vel­op­ing tar­get­ed ther­a­peu­tics in in­flam­ma­tion and im­muno-on­col­o­gy. Lead as­set, Rosip­tor, is an oral, once dai­ly, small molecule ac­ti­va­tor of SHIP1. In Ph3 for the treat­ment of... [more in­for­ma­tion]

Event Contact

Bill Kadel
Solebury Trout